TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹37 Cr | ₹32 Cr | ₹38 Cr | ₹3.10 Cr |
What is the latest Net Current Assets ratio of TRIDENT LIFELINE ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹3.10 Cr |
How is Net Current Assets of TRIDENT LIFELINE Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 16.07 | |
| Mar2024 | ₹32 Cr | -15.81 | |
| Mar2023 | ₹38 Cr | 1,116.93 | |
| Mar2022 | ₹3.10 Cr | - | |
Compare Net Current Assets of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹365.2 Cr | -0.1% | 1.9% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -0.1% |
1.9% |
6.8% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses